|
TOFU THERAPY
By Sean Henahan, Access Excellence
SAN ANTONIO-
Estrogens derived from soybeans and other
plants may offer a promising therapeutic alternative to
pharmaceutical estrogens currently in use, reported researchers
at the 35th Annual Conference on Cardiovascular Disease
Epidemiology and Prevention.
Estrogens derived from mammalian sources are widely used for
contraception in pre-menopausal women and to reduce the risk of
heart disease and osteoporosis in post-menopausal women. However,
there are lingering concerns that estrogen therapy may increase
the risk for cancers of the breast and endometrium in some women.
Therefore, researchers would like to safer alternative to current
estrogen regimens.
Estrogens are also found in more than 300 species of plants.
IN preliminary animal studies, soy estrogens have been
demonstrated to prevent the development of breast cancer. There
is also some indication that women who live in areas where soy is
an important component of the diet may have a lower incidence of
some cancers. This led researchers at Bowman Gray School of
Medicine to conduct a series of diet studies in non-human
primates.
"We chose soy protein because of the cross-cultural evidence
that Japanese who eat a lot of soy have lower rates of heart
disease, breast cancer, endometrial cancer and hip fractures. It
look like these plant estrogens may be beneficial in all these
diseases that affect women," said Mary Anthony, of Bowman Gray
School of Medicine, Winston-Salem, NC.
The researchers randomly assigned 153 macaques to one of
three diets: animal protein (casein), soy protein with
phytoestrogens intact, or soy protein with phytoestrogens
removed. The amounts of fat and cholesterol were the same in all
diets. The researchers then measured levels of different types of
cholesterol at two, four and six month after beginning the study.
The study showed that levels of LDL and VLDL (two types of
'bad' cholesterol) were highest in the animal protein diet group,
slightly lower in the modified soy diet and significantly lower
in the group receiving the soy diet with intact phytoestrogens.
HDL ('good' cholesterol) levels were highest in the
soy-phytoestrogen diet group, lower in the depleted soy diet
group and lowest in the animal protein diet group, said Anthony.
"These data suggest that soy protein has a beneficial effect
on lipid profiles compared to animal protein, and that at least
some of the effect is attributable to the phytoestrogens. IN
addition, the data are compatible with cross-cultural studies
that show lower rates of coronary heart disease in countries with
greater consumption of soy," she reported
While the long term effects of soy on risk of osteoporosis,
coronary heart disease and cancer have yet to be determined in
western countries, dietary soy supplementation may potentially be
a more acceptable method of hormone replacement than current
therapies, she noted.
The researchers are also evaluating the safety of
phytoestrogens in animal studies. Early results indicate that
phytoestrogen consumption is not associated with excessive cell
growth in the endometrium.
"At least currently, we have seen no negative effects on the
cells like we see with the mammalian estrogens, which are behind
the increased endometrial cancer rates," she said.
Transmitted: 95-03-09 16:15:18 EST
|